M998
Morphology Classification: Myelodysplastic syndromes
- M9980/1Refractory anaemia NOS, uncertain whether benign or malignant (D46.4)
- M9980/3Refractory anaemia, malignant, primary site
- M9980/6Refractory anaemia, malignant, metastatic site
- M9981/1Refractory anaemia without sideroblasts, uncertain whether benign or malignant (D46.0)
- M9982/1Refractory anaemia with sideroblasts, uncertain whether benign or malignant (D46.1)
- M9982/3Refractory anaemia with sideroblasts, malignant, primary site (D46.1)
- M9982/6Refractory anaemia with sideroblasts, malignant, metastatic site
- M9983/1Refractory anaemia with excess of blasts, uncertain whether benign or malignant (D46.2)
- M9983/3Refractory anaemia with excess blasts, malignant, primary site
- M9983/6Refractory anaemia with excess blasts, malignant, metastatic site
- M9984/1Refractory anaemia with excess of blasts with transformation, uncertain whether benign or malignant (D46.3)
- M9984/3Refractory anaemia with excess blasts in transformation, malignant, primary site
- M9984/6Refractory anaemia with excess blasts in transformation, malignant, metastatic site
- M9985/3Refractory cytopenia with multilineage dysplasia, malignant, primary site
- M9985/6Refractory cytopenia with multilineage dysplasia, malignant, metastatic site
- M9986/3Myelodysplastic syndrome with 5q deletion (5q-) syndrome, malignant, primary site
- M9986/6Myelodysplastic syndrome with 5q deletion (5q-) syndrome, malignant, metastatic site
- M9987/3Therapy-related myelodysplastic syndrome, NOS, malignant, primary site
- M9987/6Therapy-related myelodysplastic syndrome, NOS, malignant, metastatic site
- M9989/1Myelodysplastic syndrome NOS, uncertain whether benign or malignant (D46.9)
- M9989/3Myelodysplastic syndrome, NOS, malignant, primary site
- M9989/6Myelodysplastic syndrome, NOS, malignant, metastatic site